{
    "Test Name": "Hereditary Endocrine Cancer Panel (NGS)",
    "Specimen Type": "Genomic DNA (extracted from patient specimen)",
    "Purpose": "To detect and characterize genetic variants associated with hereditary endocrine cancers using next-generation sequencing.",
    "Container": "Not specified",
    "Equipment": "NGS instrument (e.g., Illumina MiSeq or NextSeq), DNA quantification device (e.g., Qubit), Bioanalyzer"
}